Lu-Gang Yu

9PUBLICATIONS
10CO-AUTHORS
GlycoconjugatesMolecular targetsPredictive and prognostic markersAgricultural molecular engineering of nucleic acids and proteinsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 15, 2026
Developing Galectin-3-Targeted Therapeutics in Diseases: Three Distinct Galectin-3 Segments for Targeting.

|Aug 23, 2023
C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression.

Yangu Wan, Kareena Adair, Anne Herrmann

|Apr 13, 2023
Galectin-3 promotes secretion of proteases that decrease epithelium integrity in human colon cancer cells.

Shun Li, David Mark Pritchard, Lu-Gang Yu

|Jan 08, 2023
Galectin-2 in Health and Diseases.

Muhammed N Negedu, Carrie A Duckworth, Lu-Gang Yu

|Oct 27, 2022
Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression.

Yaoyu Pang, Ellen Maxwell, Paulina Sindrewicz-Goral

|Jul 09, 2022
Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.

Shun Li, David Mark Pritchard, Lu-Gang Yu

Pageof 2

Frequent Collaborators

1 joint publications

Susanna Dodd

1 joint publications

Sreedhar Subramanian

1 joint publications

Andrew Shapanis

1 joint publications

Mark Morgan